Rat VEGF-D / VEGFD / FIGF Protein (Fc Tag)
FIGF, Vegfd
- 100ug (NPP1603) Please inquiry
| Catalog Number | P80104-R01H |
|---|---|
| Organism Species | Rat |
| Host | Human Cells |
| Synonyms | FIGF, Vegfd |
| Molecular Weight | The recombinant Rat FIGF/Fc comprises 377 amino acids and has a predicted molecular mass of 41.6 kDa. The apparent molecular mass of the protein is approximately 52 kDa in SDS-PAGE under reducing conditions. |
| predicted N | Glu |
| SDS-PAGE |  |
| Purity | > 85 % as determined by SDS-PAGE |
| Protein Construction | A DNA sequence encoding the rat FIGF (Phe94-Arg210) was expressed, fused with the Fc region of human IgG1 at the N-terminus. |
| Bio-activity | Measured by its binding ability in a functional ELISA. Immobilized recombinant Rat VEGF-Dprotein (P80104-R01H) at 10 µg/mL (100 µl/well) can bind biotinylated mouse VEGFR3-Fc (P50584-M02H) with a linear range of 31.25-2000 ng/mL. |
| Research Area | Cardiovascular |Angiogenesis |Growth Factor & Receptor |Vascular Endothelial Growth Factor (VEGF) & Receptor |Vascular Endothelial Growth Factor (VEGF) |
| Formulation | Lyophilized from sterile PBS, pH 7.4 1. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA. |
| Background | Vascular endothelial growth factor D (VEGF-D), also known as C-fos induced growth factor (FIGF), belongs to the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family. FIGF protein is active in angiogenesis, lymphangiogenesis, and endothelial cell growth. FIGF protein is secreted as a non-covelent homodimer in an antiparallel fashion. Human FIGF protein is expressed in adult lung, heart, muscle, and small intestine, and is most abundantly expressed in fetal lungs and skin. FIGF protein is structurally and functionally similar to VEGF-C. Therefore, FIGF protein binds and activates VEGFR-2 (Flk1) and VEGFR-3 (Flt4) receptors, and may particularly be involved in cancers, such as breast cancer, epithelial ovarian carcinoma and so on. |
| Reference |